Qlife Holding
0,001 SEK +22,22%HC Andersen Capital har tidligere modtaget betaling fra Qlife Holding for en Digital IR/Corporate Visibility abonnementsaftale. Hermed kan der være betalt materiale, som ikke er opdateret. Læs mere her.
Qlife Holding AB er et medico teknisk selskab, der stræber efter at revolutionere markedet for kliniske biomarkør- og virustest. Ved at muliggøre test derhjemme som et supplement til test i sundhedssystemet, lettes adgang til vigtige sundhedsinformationer, hvilket kan bidrage til bedre behandling og potentielt forebygge sygdomme. De første testkapsler i virksomhedens brand, Egoo. Health Platform, blev CE-mærket til professionelt brug i begyndelsen af 2020. Virksomheden har patentbeskyttelse for centrale dele af sin teknologi. Det danske selskab er noteret på Nasdaq First North Stockholm.
Læs mereSeneste analyser
Analyst
![Claus Thestrup Claus Thestrup](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90,fit=cover/https://content.inderes.se/assets/637ef734-dcbf-426c-bf91-0ac4a79aa71e.png)
![Henrik Ekman Henrik Ekman](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90,fit=cover/https://content.inderes.se/assets/6e03ef5d-f5bb-4113-a20b-1a7d036027c4.png)
Seneste videoer
Finanskalender
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Nordnet Pensionsförsäkring | 7,4 % | 7,4 % |
Försäkringsbolaget Avanza Pension | 5,4 % | 5,4 % |
Premium
This content is for our Premium customers only.
Forum opdateringer
Avstämningsdag för sammanläggning av aktier i Qlife Holding AB
Qlife Holding AB: Qlife participates research trial for people living with PKU and gets positive data
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Kommuniké från årsstämma 2024 i Qlife Holding AB
Qlife Holding AB loses arbitration proceedings against Aidian
Qlife Holding AB publishes information by reason of ongoing negotiations with Atlas Special Opportunities, LLC, regarding a financing solution
Qlife Holding AB: The exercise period for warrants series TO 4 in Qlife Holding begins today
Qlife Holding AB publishes 2023 annual report
Qlife Holding AB: Qlife starts clinical trial in China with first biomarker on Egoo Health
Qlife Holding AB: QLIFE HOLDING AB, Interim Report Q1, January to March 2024
Kallelse till årsstämma 2024 i Qlife Holding AB
Qlife Holding AB enters into an addendum with the holders of the company's convertible debentures and all outstanding convertible debentures are converted into shares
Bulletin from the extraordinary general meeting, and the first meeting for liquidation purposes, in Qlife Holding AB on 23 April 2024
Qlife Holding AB: CORRECTION Qlife informs that it has put its Danish operational company into reconstruction mode as a temporary measure
Qlife Holding AB: Qlife informs that it has put its Danish operational company into reconstruction mode as a temporary measure
![Dagens aktienyheder 03/04: Danske Bank, Skjern Bank, WindowMaster og Qlife](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/84ea8977-34ae-494d-9866-d121ccc33e06.png)
Dagens aktienyheder 03/04: Danske Bank, Skjern Bank, WindowMaster og Qlife
Qlife Holding AB: Qlife announces the last day for trading in BTU and the first day for trading in warrants series TO 4 and TO 5
Qlife Holding AB: UPDATE: Qlife is emphasizing its strategy to finalize regulatory and Go-To-Market in China, register in Asian countries through partners, and then file for approval in the UK and EU
![Dagens aktienyheder 25/03: Shape Robotics GomSpace, MapsPeople, NeoDynamics og Qlife](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/84ea8977-34ae-494d-9866-d121ccc33e06.png)